Union Heritage Capital’s AbbVie ABBV Stock Holding History

Union Heritage Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.86M	Hold	23,281	–	–	1.99%	20
2026 Q1	$5.06M	Hold	23,281	–	–	1.88%	22
2025 Q4	$5.32M	Hold	23,281	–	–	1.8%	18
2025 Q3	$5.39M	Hold	23,281	–	–	1.75%	18
2025 Q2	$4.32M	Hold	23,281	–	–	1.51%	22
2025 Q1	$4.88M	Hold	23,281	–	–	1.82%	20
2024 Q4	$4.14M	Hold	23,281	–	–	1.53%	25
2024 Q3	$4.6M	Hold	23,281	–	–	1.7%	24
2024 Q2	$3.99M	Hold	23,281	–	–	1.57%	25
2024 Q1	$4.24M	Buy	23,281 +3,581	+18%	+$617K	1.68%	24
2023 Q4	$3.05M	Hold	19,700	–	–	1.58%	26
2023 Q3	$2.94M	Hold	19,700	–	–	1.67%	25
2023 Q2	$2.65M	Hold	19,700	–	–	1.44%	27
2023 Q1	$3.14M	Hold	19,700	–	–	1.91%	22
2022 Q4	$3.18M	Hold	19,700	–	–	1.94%	22
2022 Q3	$2.64M	Hold	19,700	–	–	1.76%	23
2022 Q2	$3.02M	Hold	19,700	–	–	1.94%	22
2022 Q1	$3.19M	Sell	19,700 -1,580	-7%	-$230K	1.77%	22
2021 Q4	$2.88M	Hold	21,280	–	–	1.35%	27
2021 Q3	$2.29M	Hold	21,280	–	–	1.08%	33
2021 Q2	$2.4M	Hold	21,280	–	–	1.12%	32
2021 Q1	$2.3M	Buy	+21,280	New	+$2.28M	1.15%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Union Heritage Capital's ABBV Position: Q2 2026 in Review

Union Heritage Capital held its AbbVie (ABBV) position steady in Q2 2026 at 23,281 shares worth $5.86M. The position accounts for 1.99% of the portfolio, ranked #20.

Union Heritage Capital first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Union Heritage Capital held 23,281 shares of AbbVie worth $5.86M as of Q2 2026.
Union Heritage Capital left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.99% of Union Heritage Capital's portfolio in Q2 2026, its #20 holding.
Union Heritage Capital first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Union Heritage Capital's 13F filing for Q2 2026, filed 14 Aug 2026.